From GlobeNewswire:

Citeline, a Norstella company, is offering exclusive access to insights from the 42nd Annual J.P. Morgan Healthcare Conference from Jan. 8-11, 2024 in San Francisco. The conference brings together industry leaders, emerging companies, and the investment community to discuss market trends and innovations. Citeline will provide daily updates and insights from JPM24 and host a webinar on Feb. 6 to discuss key takeaways. Register for access to Citeline’s JPM updates. For access to Scrip and Biomedtracker, visit Citeline. Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals. They provide data and insights to drive clinical, commercial, and regulatory-related decisions to create real-world opportunities for growth. Citeline’s global teams cover key diseases, clinical trials, drug R&D and approvals, and market forecasts with expert insights. Follow Citeline on LinkedIn and X (formerly Twitter). For more information, visit Citeline. Contact Diffusion PR for Citeline at [email protected] or (213) 318-4500.



Read more: Citeline to Share Exclusive Insights from 42nd Annual J.P.